莱美药业
(300006)
| 流通市值：56.70亿 | | | 总市值：56.70亿 |
| 流通股本：10.56亿 | | | 总股本：10.56亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 350,442,837.47 | 182,210,103.8 | 775,686,202.33 | 581,062,830.69 |
| 营业总成本 | 360,253,634.53 | 189,415,653.02 | 853,327,387.5 | 627,339,724.72 |
| 其他经营收益 | | | | |
| 营业利润 | -22,191,204.53 | -17,050,190.46 | -146,169,088.28 | -47,389,500.88 |
| 利润总额 | -22,405,651.37 | -17,107,840.01 | -146,812,453.37 | -47,587,538.64 |
| 净利润 | -22,655,148.78 | -13,581,804.19 | -126,531,916.8 | -44,921,842.66 |
| 每股收益 | | | | |
| 其他综合收益 | -7,299,970.49 | - | -16,260,693.68 | - |
| 综合收益总额 | -29,955,119.27 | -13,581,804.19 | -142,792,610.48 | -44,921,842.66 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,691,565,943.5 | 1,569,945,880.06 | 1,521,339,931.4 | 1,671,225,885.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,040,038,516.75 | 1,042,505,001.66 | 1,053,376,778 | 1,091,090,340.91 |
| 资产总计 | 2,731,604,460.25 | 2,612,450,881.72 | 2,574,716,709.4 | 2,762,316,226.22 |
| 流动负债: | | | | |
| 流动负债合计 | 852,171,257.35 | 780,593,736.68 | 728,488,867.76 | 818,447,336.45 |
| 非流动负债: | | | | |
| 非流动负债合计 | 130,093,095.64 | 72,257,479.13 | 82,160,371.58 | 91,871,154.55 |
| 负债合计 | 982,264,352.99 | 852,851,215.81 | 810,649,239.34 | 910,318,491 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,731,136,643.89 | 1,740,876,645.98 | 1,755,889,329.58 | 1,838,679,559.69 |
| 股东权益合计 | 1,749,340,107.26 | 1,759,599,665.91 | 1,764,067,470.06 | 1,851,997,735.22 |
| 负债和股东权益合计 | 2,731,604,460.25 | 2,612,450,881.72 | 2,574,716,709.4 | 2,762,316,226.22 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 585,064,034.57 | 269,311,259.28 | 1,276,772,703.05 | 930,748,627.65 |
| 经营活动现金流出小计 | 561,245,117.34 | 302,565,962.86 | 1,250,734,948.37 | 934,196,514.06 |
| 经营活动产生的现金流量净额 | 23,818,917.23 | -33,254,703.58 | 26,037,754.68 | -3,447,886.41 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 15,179,734.62 | 1,329,250.65 | 30,589,293.56 | 27,055,291.65 |
| 投资活动现金流出小计 | 35,052,162.66 | 7,582,823.72 | 81,990,333.46 | 70,300,299.69 |
| 投资活动产生的现金流量净额 | -19,872,428.04 | -6,253,573.07 | -51,401,039.9 | -43,245,008.04 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 364,576,652.66 | 155,564,687.91 | 326,323,457.57 | 290,175,676.14 |
| 筹资活动现金流出小计 | 219,763,174.57 | 120,707,398.54 | 444,287,142.18 | 268,655,372.51 |
| 筹资活动产生的现金流量净额 | 144,813,478.09 | 34,857,289.37 | -117,963,684.61 | 21,520,303.63 |
| 汇率变动对现金及现金等价物的影响 | -1,324,656.04 | -665,047.74 | -962,385.63 | -498,142.03 |
| 现金及现金等价物净增加额 | 147,435,311.24 | -5,316,035.02 | -144,289,355.46 | -25,670,732.85 |
| 期末现金及现金等价物余额 | 1,028,821,396.94 | 876,070,050.68 | 881,386,085.7 | 1,000,004,708.31 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 147,435,311.24 | - | -144,289,355.46 | - |